Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Aims Patients with type 2 diabetes (T2D) have an increased risk of cardiovascular disease. Recent cardiovascular outcome trials (CVOTs) with liraglutide, semaglutide, and albiglutide have shown significant reduction in major adverse cardiovascular events. Conversely, the CVOT with exenatide long-act...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta diabetologica 2019-09, Vol.56 (9), p.1051-1060
Hauptverfasser:	Bonora, B. M., Avogaro, A., Fadini, G. P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics Cardiovascular diseases Clinical trials Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diuretics Health risk assessment Internal Medicine Medicine Medicine & Public Health Meta-analysis Metabolic Diseases Mortality Original Article Patients Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!